Further prognostic analysis showed that elevated NOP2 expression was associated with poor prognosis in ccRCC patients and that incorporating NOP2 expression could assist in the predictive ability of the clinical prognostic model, suggesting that NOP2 may be a biomarker for ccRCC prognosis. This evidence concerns the gene NOP2 and nonpapillary renal cell carcinoma.